CRIS Curis Inc stock chart & analysis

Conviction 40HealthcareScan · Tue, Nov 3, 2026

Curis Inc (CRIS) closed at $0.6896 (+4.33%) on Nov 3, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 51, RS Rating 1, -97.3% from its 52-week high, -95.6% year to date. Sector: Healthcare · Biological Products, (No Diagnostic Substances).

CRIS$0.6896+4.33%

ResistanceSupportVol 14

Loading chart…

Why CRIS moved

From the StockSetups movers recaps that covered CRIS, newest first. A recap states what was known that day.

Nov 3, 2026After hours+45.0%
Curis jumped 45.0% after the bell to $1.00 on 49,122,434 after-hours shares. Its 20-day average daily volume is 1,561,442, so one evening traded far more than a typical full day. The market cap is only $1.4M, which makes the stock extremely fragile. The move is measured against the 4:00 PM ET regular-session close.
After-Hours Movers Nov 3, 2026: Why CRIS, DKI, FTK Jumped →

Curis IncBiological Products, (No Diagnostic Substances)www.curis.com ↗

Price0.6896

Change+4.33%

Gap+9.30%

Rel volume27.69×

Avg volume1.56M

Avg $ vol978.35K

SMA 200.5294

SMA 500.8849

SMA 2007.27

Price vs 50-22.07%

Price vs 200-90.51%

MA stackbearish

50/200 cross—

Supertrendup · 0.5145

RSI (14)51

MACD hist0.07

MACD cross—

Stoch %K / %D31 / 61

ADX (14)59

+DI / −DI47 / 13

RSI divergenceBullish

MACD divergenceBullish

ATR %23.68%

ADR %22.75%

52w high25.44

52w low0.3250

From 52w high-97.29%

Above 52w low+112.18%

New 52w highNo

SqueezeOff

Bollinger width96.01%

%B0.82

Donchian pos31.30%

Donchian high1.49

Donchian low0.3250

AVWAP (52w high)2.73

vs AVWAP high-74.75%

AVWAP (52w low)0.7779

vs AVWAP low-11.36%

OBV trendUp

Chaikin MF (20)-0.50

Today vs 20d27.69×

Avg vol (14d)2.15M

Avg vol (20d)1.56M

Avg $ vol (20d)978.35K

Market cap1.44M

RS Rating1 / 99

RS 3m (vs SPY)-82.82%

RS 6m (vs SPY)-96.67%

RS line new highNo

Trend template1/8

Technical rank15.4

1 week+71.33%

1 month-12.60%

3 months-84.83%

6 months-92.44%

1 year-97.11%

YTD-95.63%

P/E-0.19

P/B0.31

P/S0.15

P/FCF-0.05

EPS-0.5800

Div yield—

ROE-161.49%

ROA-39.97%

Debt/Eq0.00

Current0.49

EV/EBITDA0.66

Gross margin—

Net margin-80.29%

Rev growth-13.43%

EPS growth82.53%

Price target—

Target upside—

Analyst rating—

Institutional0.00%

Ent. value-3.63M

Revenue0

Net income-8.58M

Gross profit—

Free cash flow-27.2M

IndustryBiological Products, (No Diagnostic Substances)

ExchangeNasdaq

Shares out38.98M

Employees24

ListedTue, Aug 1, 2000

Free float12.66M

Float %92.2%

Short interest—

Days to cover—

Short volume43.6%

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction40 / 100

Pattern quality—

Tech rank15.4 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance0.8399

Support0.3438

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

CRIS technical analysis

Trend

CRIS is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 22.1% below the 50-day ($0.8849) and 90.5% below the 200-day ($7.27). ADX(14) at 59 points to a strong, established trend. It meets 1 of 8 trend-template criteria.

Momentum

RSI(14) is 51, in the bullish half of its range. The MACD histogram is positive. A bullish RSI divergence is in place. A bullish MACD divergence is in place. Its RS Rating of 1 puts its weighted 12-month performance ahead of about 1% of the US market.

Volume and volatility

Volume on the latest session ran 27.7× its 20-day average. It trades about $978,350 a day on average. ATR(14) is $0.1633, 23.7% of price — its typical daily range. On-balance volume is trending up. Chaikin Money Flow (-0.50) shows distribution.

Key levels

The chart pattern's support is $0.3438 and its resistance $0.8399. The 52-week range is $0.3250 to $25.44; price is 97.3% below the high and 112.2% above the low. The VWAP anchored at the 52-week high is $2.73, above price.

Performance

CRIS returned +71.3% (1 week), -12.6% (1 month), -84.8% (3 months), -92.4% (6 months), -97.1% (1 year), -95.6% (year to date).

About Curis Inc

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Biological Products, (No Diagnostic Substances) · Listed 2000 · 24 employees

Insider activity

SEC Form 4 transactions in CRIS

Insider	Side	Shares	Value	Traded	Filed
GREENACRE MARTYN D Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
Borgman Anne Elizabeth Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
Dentzer James E President & CEO · Employee stock option (right to buy) · 2026-07-07	Grant	110.09K	$582K	2026-07-07	2026-07-09
Zung Jonathan B. CDO · Employee stock option (right to buy) · 2026-07-07	Grant	48.28K	$255K	2026-07-07	2026-07-09
Duvall Diantha CFO · Employee stock option (right to buy) · 2026-07-07	Grant	48.28K	$255K	2026-07-07	2026-07-09
Hohneker John Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
KAITIN KENNETH I Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09
Rubin Marc Director · Non Qualified Stock Option · 2026-07-07	Grant	6.8K	$36K	2026-07-07	2026-07-09

SEC filings

EDGAR filings in CRIS · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.

Start free — 7-day trial, no card →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.